Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 22Uterine Cervical Neoplasms 18Uterine Cervical Dysplasia 6Condylomata Acuminata 6Anus Neoplasms 5Vulvar Neoplasms 4Vaginal Neoplasms 3HIV Infections 2Whooping Cough 1Virus Diseases 1Tetanus 1Persistent Infection 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Neoplasm Metastasis 1Meningitis 1Lung Neoplasms 1Keratosis, Actinic 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Genital Human Papilloma Virus Infection 1Endometrial Neoplasms 1Diphtheria 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 16Zidovudine 13Vincristine 12Bleomycin 11Interferon alpha-2 6Cyclophosphamide 6Methotrexate 5Liposomes 5Leucovorin 5Dexamethasone 5tecogalan 4sargramostim 4Filgrastim 4Etoposide 4Cytarabine 4Ritonavir 3Nivolumab 3Fluorouracil 3pomalidomide 2liposomal doxorubicin 2interferon alfa-n1 2Watchful Waiting 2Valganciclovir 2Tumor Necrosis Factor-alpha 2Tobacco Use Cessation Devices 2Thalidomide 2Surveys and Questionnaires 2Rituximab 2Paclitaxel 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Acquired Immunodeficiency Syndrome × Papillomavirus Vaccines × Clear all
NCT05266898 2025-04-18

AGO-Gard

Louisiana State University Health Sciences Center in New Orleans

Phase 4 Recruiting
250 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡